Intuitive Surgical Stock Drops Despite Earnings Beat; Wall Street Remains Optimistic
Friday, Jan 24, 2025 1:53 pm ET
Intuitive Surgical (ISRG) shares took a tumble Thursday, despite reporting fourth-quarter earnings that topped analysts' expectations. The stock wavered between slight gains and losses in extended trading, closing at an all-time high a day earlier and gaining about 62% over the past year through Thursday's close. The company reported fourth-quarter revenue of $2.41 billion, a 25% jump year-over-year and above the analyst consensus compiled by Visible Alpha. Earnings came in at $686 million, or $1.88 per share, up from $606 million, or $1.69 per share, a year ago and also beat expectations.

The medical device maker reported fourth-quarter adjusted earnings of $2.21 per share, beating analyst estimates of $1.79. Intuitive Surgical said the number of procedures performed with its da Vinci minimally invasive surgical devices increased 18% from a year earlier. The company said it installed 493 da Vinci systems in the period, compared to 415 a year ago. Intuitive Surgical expects da Vinci procedures this year to grow 13% to 16% from 2024. Its adjusted gross profit margin is expected to fall between 1 to 2 percentage points, but that doesn’t account for potential new tariffs, which could have a “material” impact, the company said.
Despite the strong results, Intuitive Surgical shares fell 0.3% to close at $608.66 on Thursday. The stock's high valuation, with a price-to-earnings ratio of around 80, may be challenging its growth in the short term. However, the company's strong fundamentals and industry leadership suggest that it remains a promising long-term investment.
Wall Street analysts remain optimistic about Intuitive Surgical's prospects. JP Morgan analyst Robbie Marcus maintained Intuitive Surgical with an Overweight rating and raised the price target from $575 to $675. Citigroup analyst Joanne Wuensch maintained the stock with a Buy rating and boosted the price target from $640 to $711.
In conclusion, while Intuitive Surgical's stock price dropped despite beating earnings expectations, the company's strong fundamentals and industry leadership continue to make it an attractive long-term investment. Wall Street analysts remain optimistic about the company's prospects, and its high valuation may be a temporary challenge to its growth. Investors should monitor the company's performance closely and consider the long-term potential of Intuitive Surgical's business.
Disclaimer: The news articles available on this platform are generated in whole or in part by artificial intelligence and may not have been reviewed or fact checked by human editors. While we make reasonable efforts to ensure the quality and accuracy of the content, we make no representations or warranties, express or implied, as to the truthfulness, reliability, completeness, or timeliness of any information provided. It is your sole responsibility to independently verify any facts, statements, or claims prior to acting upon them. Ainvest Fintech Inc expressly disclaims all liability for any loss, damage, or harm arising from the use of or reliance on AI-generated content, including but not limited to direct, indirect, incidental, or consequential damages.